Mepron suspension

Ingredients and appearance - Product information

Mepron suspension- Atovaquone

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 53873-000
Route of Administration Oral

Active Ingredient/Active Moiety

Ingredient Name Strength
Atovaquone ( UNII: Y883P1Z2LT)( Atovaquone - UNII: Y883P1Z2LT ) 750 mgin 5 mL

Inactive Ingredients

Ingredient Name Code
Benzyl alcohol ( UNII: LKG8494WBH)
Poloxamer 188 ( UNII: LQA7B6G8JG)
Water ( UNII: 059QF0KO0R)
Saccharin sodium ( UNII: SB8ZUX40TY)
Xanthan gum ( UNII: TTV12P4NEE)

Product Characteristics

Color YELLOW (bright yellow) Flavor ORANGE (citrus)

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Approved Drug Product Manufactured Under Contract NDA020500 USA

Labeler - GlaxoSmithKline Inc( 205556368)

Principal display panel

NDC 0173-0665-18

MEPRON ®

(atovaquone)

SUSPENSION

750 mg/ 5mL

Each 5 mL (1 teaspoonful) contains 750 mg atovaquone.

R xonly

210 mL

See accompanying prescribing information for Dosage and Administration.

Store at 15 oto 25 oC (59 oto 77 oF).

DO NOT FREEZE. Dispense in a tight container as defined in USP.

SHAKE GENTLY BEFORE USING.

Do not use if shrinkband on bottle is broken or missing

GlaxoSmithKline

Research Triangle Park, NC 27709

Made in Canada

  1. 10000000135317Rev. 6/15